抗高眼圧症薬のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Anti-intraocular Hypertension Drugs Market Insights, Forecast to 2028

• レポートコード：QY2207E10360 • 出版社/出版日：QYResearch / 2022年7月 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界の抗高眼圧症薬の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に抗高眼圧症薬の世界市場のxxx％を占める「αアゴニスト」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院薬局」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国の抗高眼圧症薬の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの抗高眼圧症薬市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの抗高眼圧症薬市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 抗高眼圧症薬のグローバル主要メーカーには、Allergen、Novartis、Santen Pharmaceutical、Akorn、AGC Chemicals、Pfizer、Emmennar、Baush Health Companies、Aerie Pharmaceuticals、Senju Pharmaceuticals、Zydus Cadila、Johnson、Merck、China Resources Zizhu Pharmaceutical、Sun Ophthalmics、Bayer、Hengrui Pharma、Ausun Pharmaceuticalなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 抗高眼圧症薬市場は、種類と用途によって区分されます。世界の抗高眼圧症薬市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 αアゴニスト、βブロッカー、プロスタグランジンアナログ、その他 【用途別セグメント】 病院薬局、小売薬局、オンライン薬局 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 抗高眼圧症薬製品概要 - 種類別市場（αアゴニスト、βブロッカー、プロスタグランジンアナログ、その他） - 用途別市場（病院薬局、小売薬局、オンライン薬局） - 調査の目的 ・エグゼクティブサマリー - 世界の抗高眼圧症薬販売量予測2017-2028 - 世界の抗高眼圧症薬売上予測2017-2028 - 抗高眼圧症薬の地域別販売量 - 抗高眼圧症薬の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別抗高眼圧症薬販売量 - 主要メーカー別抗高眼圧症薬売上 - 主要メーカー別抗高眼圧症薬価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（αアゴニスト、βブロッカー、プロスタグランジンアナログ、その他） - 抗高眼圧症薬の種類別販売量 - 抗高眼圧症薬の種類別売上 - 抗高眼圧症薬の種類別価格 ・用途別市場規模（病院薬局、小売薬局、オンライン薬局） - 抗高眼圧症薬の用途別販売量 - 抗高眼圧症薬の用途別売上 - 抗高眼圧症薬の用途別価格 ・北米市場 - 北米の抗高眼圧症薬市場規模（種類別、用途別） - 主要国別の抗高眼圧症薬市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの抗高眼圧症薬市場規模（種類別、用途別） - 主要国別の抗高眼圧症薬市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の抗高眼圧症薬市場規模（種類別、用途別） - 主要国別の抗高眼圧症薬市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の抗高眼圧症薬市場規模（種類別、用途別） - 主要国別の抗高眼圧症薬市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの抗高眼圧症薬市場規模（種類別、用途別） - 主要国別の抗高眼圧症薬市場規模（トルコ、サウジアラビア） ・企業情報 Allergen、Novartis、Santen Pharmaceutical、Akorn、AGC Chemicals、Pfizer、Emmennar、Baush Health Companies、Aerie Pharmaceuticals、Senju Pharmaceuticals、Zydus Cadila、Johnson、Merck、China Resources Zizhu Pharmaceutical、Sun Ophthalmics、Bayer、Hengrui Pharma、Ausun Pharmaceutical ・産業チェーン及び販売チャネル分析 - 抗高眼圧症薬の産業チェーン分析 - 抗高眼圧症薬の原材料 - 抗高眼圧症薬の生産プロセス - 抗高眼圧症薬の販売及びマーケティング - 抗高眼圧症薬の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 抗高眼圧症薬の産業動向 - 抗高眼圧症薬のマーケットドライバー - 抗高眼圧症薬の課題 - 抗高眼圧症薬の阻害要因 ・主な調査結果

Anti-intraocular hypertension drugs are medications that can treat high intraocular pressure.
Market Analysis and Insights: Global Anti-intraocular Hypertension Drugs Market
Due to the COVID-19 pandemic, the global Anti-intraocular Hypertension Drugs market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Alpha Agonist accounting for % of the Anti-intraocular Hypertension Drugs global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital Pharmacies segment is altered to an % CAGR throughout this forecast period.
China Anti-intraocular Hypertension Drugs market size is valued at US$ million in 2021, while the US and Europe Anti-intraocular Hypertension Drugs are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Anti-intraocular Hypertension Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Anti-intraocular Hypertension Drugs include Allergen, Novartis, Santen Pharmaceutical, Akorn, AGC Chemicals, Pfizer, Emmennar, Baush Health Companies and Aerie Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Anti-intraocular Hypertension Drugs Scope and Segment
Anti-intraocular Hypertension Drugs market is segmented by Type and by Distribution Channel. Players, stakeholders, and other participants in the global Anti-intraocular Hypertension Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Distribution Channel for the period 2017-2028.
Segment by Type
Alpha Agonist
Beta Blockers
Prostaglandin Analogs
Others
Segment by Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Company
Allergen
Novartis
Santen Pharmaceutical
Akorn
AGC Chemicals
Pfizer
Emmennar
Baush Health Companies
Aerie Pharmaceuticals
Senju Pharmaceuticals
Zydus Cadila
Johnson
Merck
China Resources Zizhu Pharmaceutical
Sun Ophthalmics
Bayer
Hengrui Pharma
Ausun Pharmaceutical
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

---

1 Study Coverage
1.1 Anti-intraocular Hypertension Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Anti-intraocular Hypertension Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Alpha Agonist
1.2.3 Beta Blockers
1.2.4 Prostaglandin Analogs
1.2.5 Others
1.3 Market by Distribution Channel
1.3.1 Global Anti-intraocular Hypertension Drugs Market Size Growth Rate by Distribution Channel, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Anti-intraocular Hypertension Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Anti-intraocular Hypertension Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Anti-intraocular Hypertension Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Anti-intraocular Hypertension Drugs Sales by Region
2.4.1 Global Anti-intraocular Hypertension Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Anti-intraocular Hypertension Drugs by Region (2023-2028)
2.5 Global Anti-intraocular Hypertension Drugs Revenue by Region
2.5.1 Global Anti-intraocular Hypertension Drugs Revenue by Region (2017-2022)
2.5.2 Global Anti-intraocular Hypertension Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Anti-intraocular Hypertension Drugs Sales by Manufacturers
3.1.1 Global Top Anti-intraocular Hypertension Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Anti-intraocular Hypertension Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Anti-intraocular Hypertension Drugs in 2021
3.2 Global Anti-intraocular Hypertension Drugs Revenue by Manufacturers
3.2.1 Global Anti-intraocular Hypertension Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Anti-intraocular Hypertension Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Anti-intraocular Hypertension Drugs Revenue in 2021
3.3 Global Anti-intraocular Hypertension Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Anti-intraocular Hypertension Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Anti-intraocular Hypertension Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Anti-intraocular Hypertension Drugs Sales by Type
4.1.1 Global Anti-intraocular Hypertension Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Anti-intraocular Hypertension Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Anti-intraocular Hypertension Drugs Sales Market Share by Type (2017-2028)
4.2 Global Anti-intraocular Hypertension Drugs Revenue by Type
4.2.1 Global Anti-intraocular Hypertension Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Anti-intraocular Hypertension Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Anti-intraocular Hypertension Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Anti-intraocular Hypertension Drugs Price by Type
4.3.1 Global Anti-intraocular Hypertension Drugs Price by Type (2017-2022)
4.3.2 Global Anti-intraocular Hypertension Drugs Price Forecast by Type (2023-2028)
5 Market Size by Distribution Channel
5.1 Global Anti-intraocular Hypertension Drugs Sales by Distribution Channel
5.1.1 Global Anti-intraocular Hypertension Drugs Historical Sales by Distribution Channel (2017-2022)
5.1.2 Global Anti-intraocular Hypertension Drugs Forecasted Sales by Distribution Channel (2023-2028)
5.1.3 Global Anti-intraocular Hypertension Drugs Sales Market Share by Distribution Channel (2017-2028)
5.2 Global Anti-intraocular Hypertension Drugs Revenue by Distribution Channel
5.2.1 Global Anti-intraocular Hypertension Drugs Historical Revenue by Distribution Channel (2017-2022)
5.2.2 Global Anti-intraocular Hypertension Drugs Forecasted Revenue by Distribution Channel (2023-2028)
5.2.3 Global Anti-intraocular Hypertension Drugs Revenue Market Share by Distribution Channel (2017-2028)
5.3 Global Anti-intraocular Hypertension Drugs Price by Distribution Channel
5.3.1 Global Anti-intraocular Hypertension Drugs Price by Distribution Channel (2017-2022)
5.3.2 Global Anti-intraocular Hypertension Drugs Price Forecast by Distribution Channel (2023-2028)
6 North America
6.1 North America Anti-intraocular Hypertension Drugs Market Size by Type
6.1.1 North America Anti-intraocular Hypertension Drugs Sales by Type (2017-2028)
6.1.2 North America Anti-intraocular Hypertension Drugs Revenue by Type (2017-2028)
6.2 North America Anti-intraocular Hypertension Drugs Market Size by Distribution Channel
6.2.1 North America Anti-intraocular Hypertension Drugs Sales by Distribution Channel (2017-2028)
6.2.2 North America Anti-intraocular Hypertension Drugs Revenue by Distribution Channel (2017-2028)
6.3 North America Anti-intraocular Hypertension Drugs Market Size by Country
6.3.1 North America Anti-intraocular Hypertension Drugs Sales by Country (2017-2028)
6.3.2 North America Anti-intraocular Hypertension Drugs Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Anti-intraocular Hypertension Drugs Market Size by Type
7.1.1 Europe Anti-intraocular Hypertension Drugs Sales by Type (2017-2028)
7.1.2 Europe Anti-intraocular Hypertension Drugs Revenue by Type (2017-2028)
7.2 Europe Anti-intraocular Hypertension Drugs Market Size by Distribution Channel
7.2.1 Europe Anti-intraocular Hypertension Drugs Sales by Distribution Channel (2017-2028)
7.2.2 Europe Anti-intraocular Hypertension Drugs Revenue by Distribution Channel (2017-2028)
7.3 Europe Anti-intraocular Hypertension Drugs Market Size by Country
7.3.1 Europe Anti-intraocular Hypertension Drugs Sales by Country (2017-2028)
7.3.2 Europe Anti-intraocular Hypertension Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Anti-intraocular Hypertension Drugs Market Size by Type
8.1.1 Asia Pacific Anti-intraocular Hypertension Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Anti-intraocular Hypertension Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Anti-intraocular Hypertension Drugs Market Size by Distribution Channel
8.2.1 Asia Pacific Anti-intraocular Hypertension Drugs Sales by Distribution Channel (2017-2028)
8.2.2 Asia Pacific Anti-intraocular Hypertension Drugs Revenue by Distribution Channel (2017-2028)
8.3 Asia Pacific Anti-intraocular Hypertension Drugs Market Size by Region
8.3.1 Asia Pacific Anti-intraocular Hypertension Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Anti-intraocular Hypertension Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Anti-intraocular Hypertension Drugs Market Size by Type
9.1.1 Latin America Anti-intraocular Hypertension Drugs Sales by Type (2017-2028)
9.1.2 Latin America Anti-intraocular Hypertension Drugs Revenue by Type (2017-2028)
9.2 Latin America Anti-intraocular Hypertension Drugs Market Size by Distribution Channel
9.2.1 Latin America Anti-intraocular Hypertension Drugs Sales by Distribution Channel (2017-2028)
9.2.2 Latin America Anti-intraocular Hypertension Drugs Revenue by Distribution Channel (2017-2028)
9.3 Latin America Anti-intraocular Hypertension Drugs Market Size by Country
9.3.1 Latin America Anti-intraocular Hypertension Drugs Sales by Country (2017-2028)
9.3.2 Latin America Anti-intraocular Hypertension Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Anti-intraocular Hypertension Drugs Market Size by Type
10.1.1 Middle East and Africa Anti-intraocular Hypertension Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Anti-intraocular Hypertension Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Anti-intraocular Hypertension Drugs Market Size by Distribution Channel
10.2.1 Middle East and Africa Anti-intraocular Hypertension Drugs Sales by Distribution Channel (2017-2028)
10.2.2 Middle East and Africa Anti-intraocular Hypertension Drugs Revenue by Distribution Channel (2017-2028)
10.3 Middle East and Africa Anti-intraocular Hypertension Drugs Market Size by Country
10.3.1 Middle East and Africa Anti-intraocular Hypertension Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Anti-intraocular Hypertension Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Allergen
11.1.1 Allergen Corporation Information
11.1.2 Allergen Overview
11.1.3 Allergen Anti-intraocular Hypertension Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Allergen Anti-intraocular Hypertension Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Allergen Recent Developments
11.2 Novartis
11.2.1 Novartis Corporation Information
11.2.2 Novartis Overview
11.2.3 Novartis Anti-intraocular Hypertension Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Novartis Anti-intraocular Hypertension Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Novartis Recent Developments
11.3 Santen Pharmaceutical
11.3.1 Santen Pharmaceutical Corporation Information
11.3.2 Santen Pharmaceutical Overview
11.3.3 Santen Pharmaceutical Anti-intraocular Hypertension Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Santen Pharmaceutical Anti-intraocular Hypertension Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Santen Pharmaceutical Recent Developments
11.4 Akorn
11.4.1 Akorn Corporation Information
11.4.2 Akorn Overview
11.4.3 Akorn Anti-intraocular Hypertension Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Akorn Anti-intraocular Hypertension Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Akorn Recent Developments
11.5 AGC Chemicals
11.5.1 AGC Chemicals Corporation Information
11.5.2 AGC Chemicals Overview
11.5.3 AGC Chemicals Anti-intraocular Hypertension Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 AGC Chemicals Anti-intraocular Hypertension Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 AGC Chemicals Recent Developments
11.6 Pfizer
11.6.1 Pfizer Corporation Information
11.6.2 Pfizer Overview
11.6.3 Pfizer Anti-intraocular Hypertension Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Pfizer Anti-intraocular Hypertension Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Pfizer Recent Developments
11.7 Emmennar
11.7.1 Emmennar Corporation Information
11.7.2 Emmennar Overview
11.7.3 Emmennar Anti-intraocular Hypertension Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Emmennar Anti-intraocular Hypertension Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Emmennar Recent Developments
11.8 Baush Health Companies
11.8.1 Baush Health Companies Corporation Information
11.8.2 Baush Health Companies Overview
11.8.3 Baush Health Companies Anti-intraocular Hypertension Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Baush Health Companies Anti-intraocular Hypertension Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Baush Health Companies Recent Developments
11.9 Aerie Pharmaceuticals
11.9.1 Aerie Pharmaceuticals Corporation Information
11.9.2 Aerie Pharmaceuticals Overview
11.9.3 Aerie Pharmaceuticals Anti-intraocular Hypertension Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Aerie Pharmaceuticals Anti-intraocular Hypertension Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Aerie Pharmaceuticals Recent Developments
11.10 Senju Pharmaceuticals
11.10.1 Senju Pharmaceuticals Corporation Information
11.10.2 Senju Pharmaceuticals Overview
11.10.3 Senju Pharmaceuticals Anti-intraocular Hypertension Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Senju Pharmaceuticals Anti-intraocular Hypertension Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Senju Pharmaceuticals Recent Developments
11.11 Zydus Cadila
11.11.1 Zydus Cadila Corporation Information
11.11.2 Zydus Cadila Overview
11.11.3 Zydus Cadila Anti-intraocular Hypertension Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Zydus Cadila Anti-intraocular Hypertension Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Zydus Cadila Recent Developments
11.12 Johnson
11.12.1 Johnson Corporation Information
11.12.2 Johnson Overview
11.12.3 Johnson Anti-intraocular Hypertension Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Johnson Anti-intraocular Hypertension Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Johnson Recent Developments
11.13 Merck
11.13.1 Merck Corporation Information
11.13.2 Merck Overview
11.13.3 Merck Anti-intraocular Hypertension Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Merck Anti-intraocular Hypertension Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Merck Recent Developments
11.14 China Resources Zizhu Pharmaceutical
11.14.1 China Resources Zizhu Pharmaceutical Corporation Information
11.14.2 China Resources Zizhu Pharmaceutical Overview
11.14.3 China Resources Zizhu Pharmaceutical Anti-intraocular Hypertension Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 China Resources Zizhu Pharmaceutical Anti-intraocular Hypertension Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 China Resources Zizhu Pharmaceutical Recent Developments
11.15 Sun Ophthalmics
11.15.1 Sun Ophthalmics Corporation Information
11.15.2 Sun Ophthalmics Overview
11.15.3 Sun Ophthalmics Anti-intraocular Hypertension Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Sun Ophthalmics Anti-intraocular Hypertension Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Sun Ophthalmics Recent Developments
11.16 Bayer
11.16.1 Bayer Corporation Information
11.16.2 Bayer Overview
11.16.3 Bayer Anti-intraocular Hypertension Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Bayer Anti-intraocular Hypertension Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Bayer Recent Developments
11.17 Hengrui Pharma
11.17.1 Hengrui Pharma Corporation Information
11.17.2 Hengrui Pharma Overview
11.17.3 Hengrui Pharma Anti-intraocular Hypertension Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Hengrui Pharma Anti-intraocular Hypertension Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Hengrui Pharma Recent Developments
11.18 Ausun Pharmaceutical
11.18.1 Ausun Pharmaceutical Corporation Information
11.18.2 Ausun Pharmaceutical Overview
11.18.3 Ausun Pharmaceutical Anti-intraocular Hypertension Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Ausun Pharmaceutical Anti-intraocular Hypertension Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Ausun Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Anti-intraocular Hypertension Drugs Industry Chain Analysis
12.2 Anti-intraocular Hypertension Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Anti-intraocular Hypertension Drugs Production Mode & Process
12.4 Anti-intraocular Hypertension Drugs Sales and Marketing
12.4.1 Anti-intraocular Hypertension Drugs Sales Channels
12.4.2 Anti-intraocular Hypertension Drugs Distributors
12.5 Anti-intraocular Hypertension Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Anti-intraocular Hypertension Drugs Industry Trends
13.2 Anti-intraocular Hypertension Drugs Market Drivers
13.3 Anti-intraocular Hypertension Drugs Market Challenges
13.4 Anti-intraocular Hypertension Drugs Market Restraints
14 Key Findings in The Global Anti-intraocular Hypertension Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Anti-intraocular Hypertension Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Alpha Agonist
Table 3. Major Manufacturers of Beta Blockers
Table 4. Major Manufacturers of Prostaglandin Analogs
Table 5. Major Manufacturers of Others
Table 6. Global Anti-intraocular Hypertension Drugs Market Size Growth Rate by Distribution Channel, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Anti-intraocular Hypertension Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Anti-intraocular Hypertension Drugs Sales by Region (2017-2022) & (K Units)
Table 9. Global Anti-intraocular Hypertension Drugs Sales Market Share by Region (2017-2022)
Table 10. Global Anti-intraocular Hypertension Drugs Sales by Region (2023-2028) & (K Units)
Table 11. Global Anti-intraocular Hypertension Drugs Sales Market Share by Region (2023-2028)
Table 12. Global Anti-intraocular Hypertension Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Anti-intraocular Hypertension Drugs Revenue Market Share by Region (2017-2022)
Table 14. Global Anti-intraocular Hypertension Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 15. Global Anti-intraocular Hypertension Drugs Revenue Market Share by Region (2023-2028)
Table 16. Global Anti-intraocular Hypertension Drugs Sales by Manufacturers (2017-2022) & (K Units)
Table 17. Global Anti-intraocular Hypertension Drugs Sales Share by Manufacturers (2017-2022)
Table 18. Global Anti-intraocular Hypertension Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global Anti-intraocular Hypertension Drugs Revenue Share by Manufacturers (2017-2022)
Table 20. Anti-intraocular Hypertension Drugs Price by Manufacturers (2017-2022) &(US$/Unit)
Table 21. Global Anti-intraocular Hypertension Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Anti-intraocular Hypertension Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-intraocular Hypertension Drugs as of 2021)
Table 23. Anti-intraocular Hypertension Drugs Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Anti-intraocular Hypertension Drugs Product Offered
Table 25. Date of Manufacturers Enter into Anti-intraocular Hypertension Drugs Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Anti-intraocular Hypertension Drugs Sales by Type (2017-2022) & (K Units)
Table 28. Global Anti-intraocular Hypertension Drugs Sales by Type (2023-2028) & (K Units)
Table 29. Global Anti-intraocular Hypertension Drugs Sales Share by Type (2017-2022)
Table 30. Global Anti-intraocular Hypertension Drugs Sales Share by Type (2023-2028)
Table 31. Global Anti-intraocular Hypertension Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 32. Global Anti-intraocular Hypertension Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 33. Global Anti-intraocular Hypertension Drugs Revenue Share by Type (2017-2022)
Table 34. Global Anti-intraocular Hypertension Drugs Revenue Share by Type (2023-2028)
Table 35. Anti-intraocular Hypertension Drugs Price by Type (2017-2022) & (US$/Unit)
Table 36. Global Anti-intraocular Hypertension Drugs Price Forecast by Type (2023-2028) & (US$/Unit)
Table 37. Global Anti-intraocular Hypertension Drugs Sales by Distribution Channel (2017-2022) & (K Units)
Table 38. Global Anti-intraocular Hypertension Drugs Sales by Distribution Channel (2023-2028) & (K Units)
Table 39. Global Anti-intraocular Hypertension Drugs Sales Share by Distribution Channel (2017-2022)
Table 40. Global Anti-intraocular Hypertension Drugs Sales Share by Distribution Channel (2023-2028)
Table 41. Global Anti-intraocular Hypertension Drugs Revenue by Distribution Channel (2017-2022) & (US$ Million)
Table 42. Global Anti-intraocular Hypertension Drugs Revenue by Distribution Channel (2023-2028) & (US$ Million)
Table 43. Global Anti-intraocular Hypertension Drugs Revenue Share by Distribution Channel (2017-2022)
Table 44. Global Anti-intraocular Hypertension Drugs Revenue Share by Distribution Channel (2023-2028)
Table 45. Anti-intraocular Hypertension Drugs Price by Distribution Channel (2017-2022) & (US$/Unit)
Table 46. Global Anti-intraocular Hypertension Drugs Price Forecast by Distribution Channel (2023-2028) & (US$/Unit)
Table 47. North America Anti-intraocular Hypertension Drugs Sales by Type (2017-2022) & (K Units)
Table 48. North America Anti-intraocular Hypertension Drugs Sales by Type (2023-2028) & (K Units)
Table 49. North America Anti-intraocular Hypertension Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 50. North America Anti-intraocular Hypertension Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 51. North America Anti-intraocular Hypertension Drugs Sales by Distribution Channel (2017-2022) & (K Units)
Table 52. North America Anti-intraocular Hypertension Drugs Sales by Distribution Channel (2023-2028) & (K Units)
Table 53. North America Anti-intraocular Hypertension Drugs Revenue by Distribution Channel (2017-2022) & (US$ Million)
Table 54. North America Anti-intraocular Hypertension Drugs Revenue by Distribution Channel (2023-2028) & (US$ Million)
Table 55. North America Anti-intraocular Hypertension Drugs Sales by Country (2017-2022) & (K Units)
Table 56. North America Anti-intraocular Hypertension Drugs Sales by Country (2023-2028) & (K Units)
Table 57. North America Anti-intraocular Hypertension Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America Anti-intraocular Hypertension Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 59. Europe Anti-intraocular Hypertension Drugs Sales by Type (2017-2022) & (K Units)
Table 60. Europe Anti-intraocular Hypertension Drugs Sales by Type (2023-2028) & (K Units)
Table 61. Europe Anti-intraocular Hypertension Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 62. Europe Anti-intraocular Hypertension Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 63. Europe Anti-intraocular Hypertension Drugs Sales by Distribution Channel (2017-2022) & (K Units)
Table 64. Europe Anti-intraocular Hypertension Drugs Sales by Distribution Channel (2023-2028) & (K Units)
Table 65. Europe Anti-intraocular Hypertension Drugs Revenue by Distribution Channel (2017-2022) & (US$ Million)
Table 66. Europe Anti-intraocular Hypertension Drugs Revenue by Distribution Channel (2023-2028) & (US$ Million)
Table 67. Europe Anti-intraocular Hypertension Drugs Sales by Country (2017-2022) & (K Units)
Table 68. Europe Anti-intraocular Hypertension Drugs Sales by Country (2023-2028) & (K Units)
Table 69. Europe Anti-intraocular Hypertension Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe Anti-intraocular Hypertension Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 71. Asia Pacific Anti-intraocular Hypertension Drugs Sales by Type (2017-2022) & (K Units)
Table 72. Asia Pacific Anti-intraocular Hypertension Drugs Sales by Type (2023-2028) & (K Units)
Table 73. Asia Pacific Anti-intraocular Hypertension Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 74. Asia Pacific Anti-intraocular Hypertension Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 75. Asia Pacific Anti-intraocular Hypertension Drugs Sales by Distribution Channel (2017-2022) & (K Units)
Table 76. Asia Pacific Anti-intraocular Hypertension Drugs Sales by Distribution Channel (2023-2028) & (K Units)
Table 77. Asia Pacific Anti-intraocular Hypertension Drugs Revenue by Distribution Channel (2017-2022) & (US$ Million)
Table 78. Asia Pacific Anti-intraocular Hypertension Drugs Revenue by Distribution Channel (2023-2028) & (US$ Million)
Table 79. Asia Pacific Anti-intraocular Hypertension Drugs Sales by Region (2017-2022) & (K Units)
Table 80. Asia Pacific Anti-intraocular Hypertension Drugs Sales by Region (2023-2028) & (K Units)
Table 81. Asia Pacific Anti-intraocular Hypertension Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific Anti-intraocular Hypertension Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 83. Latin America Anti-intraocular Hypertension Drugs Sales by Type (2017-2022) & (K Units)
Table 84. Latin America Anti-intraocular Hypertension Drugs Sales by Type (2023-2028) & (K Units)
Table 85. Latin America Anti-intraocular Hypertension Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 86. Latin America Anti-intraocular Hypertension Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 87. Latin America Anti-intraocular Hypertension Drugs Sales by Distribution Channel (2017-2022) & (K Units)
Table 88. Latin America Anti-intraocular Hypertension Drugs Sales by Distribution Channel (2023-2028) & (K Units)
Table 89. Latin America Anti-intraocular Hypertension Drugs Revenue by Distribution Channel (2017-2022) & (US$ Million)
Table 90. Latin America Anti-intraocular Hypertension Drugs Revenue by Distribution Channel (2023-2028) & (US$ Million)
Table 91. Latin America Anti-intraocular Hypertension Drugs Sales by Country (2017-2022) & (K Units)
Table 92. Latin America Anti-intraocular Hypertension Drugs Sales by Country (2023-2028) & (K Units)
Table 93. Latin America Anti-intraocular Hypertension Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America Anti-intraocular Hypertension Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 95. Middle East and Africa Anti-intraocular Hypertension Drugs Sales by Type (2017-2022) & (K Units)
Table 96. Middle East and Africa Anti-intraocular Hypertension Drugs Sales by Type (2023-2028) & (K Units)
Table 97. Middle East and Africa Anti-intraocular Hypertension Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 98. Middle East and Africa Anti-intraocular Hypertension Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Anti-intraocular Hypertension Drugs Sales by Distribution Channel (2017-2022) & (K Units)
Table 100. Middle East and Africa Anti-intraocular Hypertension Drugs Sales by Distribution Channel (2023-2028) & (K Units)
Table 101. Middle East and Africa Anti-intraocular Hypertension Drugs Revenue by Distribution Channel (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Anti-intraocular Hypertension Drugs Revenue by Distribution Channel (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Anti-intraocular Hypertension Drugs Sales by Country (2017-2022) & (K Units)
Table 104. Middle East and Africa Anti-intraocular Hypertension Drugs Sales by Country (2023-2028) & (K Units)
Table 105. Middle East and Africa Anti-intraocular Hypertension Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Anti-intraocular Hypertension Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 107. Allergen Corporation Information
Table 108. Allergen Description and Major Businesses
Table 109. Allergen Anti-intraocular Hypertension Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 110. Allergen Anti-intraocular Hypertension Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Allergen Recent Developments
Table 112. Novartis Corporation Information
Table 113. Novartis Description and Major Businesses
Table 114. Novartis Anti-intraocular Hypertension Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 115. Novartis Anti-intraocular Hypertension Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Novartis Recent Developments
Table 117. Santen Pharmaceutical Corporation Information
Table 118. Santen Pharmaceutical Description and Major Businesses
Table 119. Santen Pharmaceutical Anti-intraocular Hypertension Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 120. Santen Pharmaceutical Anti-intraocular Hypertension Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Santen Pharmaceutical Recent Developments
Table 122. Akorn Corporation Information
Table 123. Akorn Description and Major Businesses
Table 124. Akorn Anti-intraocular Hypertension Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 125. Akorn Anti-intraocular Hypertension Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Akorn Recent Developments
Table 127. AGC Chemicals Corporation Information
Table 128. AGC Chemicals Description and Major Businesses
Table 129. AGC Chemicals Anti-intraocular Hypertension Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 130. AGC Chemicals Anti-intraocular Hypertension Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. AGC Chemicals Recent Developments
Table 132. Pfizer Corporation Information
Table 133. Pfizer Description and Major Businesses
Table 134. Pfizer Anti-intraocular Hypertension Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 135. Pfizer Anti-intraocular Hypertension Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Pfizer Recent Developments
Table 137. Emmennar Corporation Information
Table 138. Emmennar Description and Major Businesses
Table 139. Emmennar Anti-intraocular Hypertension Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 140. Emmennar Anti-intraocular Hypertension Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Emmennar Recent Developments
Table 142. Baush Health Companies Corporation Information
Table 143. Baush Health Companies Description and Major Businesses
Table 144. Baush Health Companies Anti-intraocular Hypertension Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 145. Baush Health Companies Anti-intraocular Hypertension Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Baush Health Companies Recent Developments
Table 147. Aerie Pharmaceuticals Corporation Information
Table 148. Aerie Pharmaceuticals Description and Major Businesses
Table 149. Aerie Pharmaceuticals Anti-intraocular Hypertension Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 150. Aerie Pharmaceuticals Anti-intraocular Hypertension Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Aerie Pharmaceuticals Recent Developments
Table 152. Senju Pharmaceuticals Corporation Information
Table 153. Senju Pharmaceuticals Description and Major Businesses
Table 154. Senju Pharmaceuticals Anti-intraocular Hypertension Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 155. Senju Pharmaceuticals Anti-intraocular Hypertension Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Senju Pharmaceuticals Recent Developments
Table 157. Zydus Cadila Corporation Information
Table 158. Zydus Cadila Description and Major Businesses
Table 159. Zydus Cadila Anti-intraocular Hypertension Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 160. Zydus Cadila Anti-intraocular Hypertension Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Zydus Cadila Recent Developments
Table 162. Johnson Corporation Information
Table 163. Johnson Description and Major Businesses
Table 164. Johnson Anti-intraocular Hypertension Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 165. Johnson Anti-intraocular Hypertension Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Johnson Recent Developments
Table 167. Merck Corporation Information
Table 168. Merck Description and Major Businesses
Table 169. Merck Anti-intraocular Hypertension Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 170. Merck Anti-intraocular Hypertension Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Merck Recent Developments
Table 172. China Resources Zizhu Pharmaceutical Corporation Information
Table 173. China Resources Zizhu Pharmaceutical Description and Major Businesses
Table 174. China Resources Zizhu Pharmaceutical Anti-intraocular Hypertension Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 175. China Resources Zizhu Pharmaceutical Anti-intraocular Hypertension Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. China Resources Zizhu Pharmaceutical Recent Developments
Table 177. Sun Ophthalmics Corporation Information
Table 178. Sun Ophthalmics Description and Major Businesses
Table 179. Sun Ophthalmics Anti-intraocular Hypertension Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 180. Sun Ophthalmics Anti-intraocular Hypertension Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 181. Sun Ophthalmics Recent Developments
Table 182. Bayer Corporation Information
Table 183. Bayer Description and Major Businesses
Table 184. Bayer Anti-intraocular Hypertension Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 185. Bayer Anti-intraocular Hypertension Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 186. Bayer Recent Developments
Table 187. Hengrui Pharma Corporation Information
Table 188. Hengrui Pharma Description and Major Businesses
Table 189. Hengrui Pharma Anti-intraocular Hypertension Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 190. Hengrui Pharma Anti-intraocular Hypertension Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 191. Hengrui Pharma Recent Developments
Table 192. Ausun Pharmaceutical Corporation Information
Table 193. Ausun Pharmaceutical Description and Major Businesses
Table 194. Ausun Pharmaceutical Anti-intraocular Hypertension Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 195. Ausun Pharmaceutical Anti-intraocular Hypertension Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 196. Ausun Pharmaceutical Recent Developments
Table 197. Key Raw Materials Lists
Table 198. Raw Materials Key Suppliers Lists
Table 199. Anti-intraocular Hypertension Drugs Distributors List
Table 200. Anti-intraocular Hypertension Drugs Customers List
Table 201. Anti-intraocular Hypertension Drugs Market Trends
Table 202. Anti-intraocular Hypertension Drugs Market Drivers
Table 203. Anti-intraocular Hypertension Drugs Market Challenges
Table 204. Anti-intraocular Hypertension Drugs Market Restraints
Table 205. Research Programs/Design for This Report
Table 206. Key Data Information from Secondary Sources
Table 207. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-intraocular Hypertension Drugs Product Picture
Figure 3. Global Anti-intraocular Hypertension Drugs Market Share by Type in 2021 & 2028
Figure 3. Alpha Agonist Product Picture
Figure 4. Beta Blockers Product Picture
Figure 5. Prostaglandin Analogs Product Picture
Figure 6. Others Product Picture
Figure 7. Global Anti-intraocular Hypertension Drugs Market Share by Distribution Channel in 2021 & 2028
Figure 8. Hospital Pharmacies
Figure 9. Retail Pharmacies
Figure 10. Online Pharmacies
Figure 11. Anti-intraocular Hypertension Drugs Report Years Considered
Figure 12. Global Anti-intraocular Hypertension Drugs Sales 2017-2028 (K Units)
Figure 13. Global Anti-intraocular Hypertension Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Anti-intraocular Hypertension Drugs Revenue 2017-2028 (US$ Million)
Figure 15. Global Anti-intraocular Hypertension Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 16. Global Anti-intraocular Hypertension Drugs Sales Market Share by Region (2017-2022)
Figure 17. Global Anti-intraocular Hypertension Drugs Sales Market Share by Region (2023-2028)
Figure 18. North America Anti-intraocular Hypertension Drugs Sales YoY (2017-2028) & (K Units)
Figure 19. North America Anti-intraocular Hypertension Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Europe Anti-intraocular Hypertension Drugs Sales YoY (2017-2028) & (K Units)
Figure 21. Europe Anti-intraocular Hypertension Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Asia-Pacific Anti-intraocular Hypertension Drugs Sales YoY (2017-2028) & (K Units)
Figure 23. Asia-Pacific Anti-intraocular Hypertension Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Latin America Anti-intraocular Hypertension Drugs Sales YoY (2017-2028) & (K Units)
Figure 25. Latin America Anti-intraocular Hypertension Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Middle East & Africa Anti-intraocular Hypertension Drugs Sales YoY (2017-2028) & (K Units)
Figure 27. Middle East & Africa Anti-intraocular Hypertension Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 28. The Anti-intraocular Hypertension Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 29. The Top 5 and 10 Largest Manufacturers of Anti-intraocular Hypertension Drugs in the World: Market Share by Anti-intraocular Hypertension Drugs Revenue in 2021
Figure 30. Global Anti-intraocular Hypertension Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 31. Global Anti-intraocular Hypertension Drugs Sales Market Share by Type (2017-2028)
Figure 32. Global Anti-intraocular Hypertension Drugs Revenue Market Share by Type (2017-2028)
Figure 33. Global Anti-intraocular Hypertension Drugs Sales Market Share by Distribution Channel (2017-2028)
Figure 34. Global Anti-intraocular Hypertension Drugs Revenue Market Share by Distribution Channel (2017-2028)
Figure 35. North America Anti-intraocular Hypertension Drugs Sales Market Share by Type (2017-2028)
Figure 36. North America Anti-intraocular Hypertension Drugs Revenue Market Share by Type (2017-2028)
Figure 37. North America Anti-intraocular Hypertension Drugs Sales Market Share by Distribution Channel (2017-2028)
Figure 38. North America Anti-intraocular Hypertension Drugs Revenue Market Share by Distribution Channel (2017-2028)
Figure 39. North America Anti-intraocular Hypertension Drugs Sales Share by Country (2017-2028)
Figure 40. North America Anti-intraocular Hypertension Drugs Revenue Share by Country (2017-2028)
Figure 41. United States Anti-intraocular Hypertension Drugs Revenue (2017-2028) & (US$ Million)
Figure 42. Canada Anti-intraocular Hypertension Drugs Revenue (2017-2028) & (US$ Million)
Figure 43. Europe Anti-intraocular Hypertension Drugs Sales Market Share by Type (2017-2028)
Figure 44. Europe Anti-intraocular Hypertension Drugs Revenue Market Share by Type (2017-2028)
Figure 45. Europe Anti-intraocular Hypertension Drugs Sales Market Share by Distribution Channel (2017-2028)
Figure 46. Europe Anti-intraocular Hypertension Drugs Revenue Market Share by Distribution Channel (2017-2028)
Figure 47. Europe Anti-intraocular Hypertension Drugs Sales Share by Country (2017-2028)
Figure 48. Europe Anti-intraocular Hypertension Drugs Revenue Share by Country (2017-2028)
Figure 49. Germany Anti-intraocular Hypertension Drugs Revenue (2017-2028) & (US$ Million)
Figure 50. France Anti-intraocular Hypertension Drugs Revenue (2017-2028) & (US$ Million)
Figure 51. U.K. Anti-intraocular Hypertension Drugs Revenue (2017-2028) & (US$ Million)
Figure 52. Italy Anti-intraocular Hypertension Drugs Revenue (2017-2028) & (US$ Million)
Figure 53. Russia Anti-intraocular Hypertension Drugs Revenue (2017-2028) & (US$ Million)
Figure 54. Asia Pacific Anti-intraocular Hypertension Drugs Sales Market Share by Type (2017-2028)
Figure 55. Asia Pacific Anti-intraocular Hypertension Drugs Revenue Market Share by Type (2017-2028)
Figure 56. Asia Pacific Anti-intraocular Hypertension Drugs Sales Market Share by Distribution Channel (2017-2028)
Figure 57. Asia Pacific Anti-intraocular Hypertension Drugs Revenue Market Share by Distribution Channel (2017-2028)
Figure 58. Asia Pacific Anti-intraocular Hypertension Drugs Sales Share by Region (2017-2028)
Figure 59. Asia Pacific Anti-intraocular Hypertension Drugs Revenue Share by Region (2017-2028)
Figure 60. China Anti-intraocular Hypertension Drugs Revenue (2017-2028) & (US$ Million)
Figure 61. Japan Anti-intraocular Hypertension Drugs Revenue (2017-2028) & (US$ Million)
Figure 62. South Korea Anti-intraocular Hypertension Drugs Revenue (2017-2028) & (US$ Million)
Figure 63. India Anti-intraocular Hypertension Drugs Revenue (2017-2028) & (US$ Million)
Figure 64. Australia Anti-intraocular Hypertension Drugs Revenue (2017-2028) & (US$ Million)
Figure 65. China Taiwan Anti-intraocular Hypertension Drugs Revenue (2017-2028) & (US$ Million)
Figure 66. Indonesia Anti-intraocular Hypertension Drugs Revenue (2017-2028) & (US$ Million)
Figure 67. Thailand Anti-intraocular Hypertension Drugs Revenue (2017-2028) & (US$ Million)
Figure 68. Malaysia Anti-intraocular Hypertension Drugs Revenue (2017-2028) & (US$ Million)
Figure 69. Latin America Anti-intraocular Hypertension Drugs Sales Market Share by Type (2017-2028)
Figure 70. Latin America Anti-intraocular Hypertension Drugs Revenue Market Share by Type (2017-2028)
Figure 71. Latin America Anti-intraocular Hypertension Drugs Sales Market Share by Distribution Channel (2017-2028)
Figure 72. Latin America Anti-intraocular Hypertension Drugs Revenue Market Share by Distribution Channel (2017-2028)
Figure 73. Latin America Anti-intraocular Hypertension Drugs Sales Share by Country (2017-2028)
Figure 74. Latin America Anti-intraocular Hypertension Drugs Revenue Share by Country (2017-2028)
Figure 75. Mexico Anti-intraocular Hypertension Drugs Revenue (2017-2028) & (US$ Million)
Figure 76. Brazil Anti-intraocular Hypertension Drugs Revenue (2017-2028) & (US$ Million)
Figure 77. Argentina Anti-intraocular Hypertension Drugs Revenue (2017-2028) & (US$ Million)
Figure 78. Colombia Anti-intraocular Hypertension Drugs Revenue (2017-2028) & (US$ Million)
Figure 79. Middle East and Africa Anti-intraocular Hypertension Drugs Sales Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Anti-intraocular Hypertension Drugs Revenue Market Share by Type (2017-2028)
Figure 81. Middle East and Africa Anti-intraocular Hypertension Drugs Sales Market Share by Distribution Channel (2017-2028)
Figure 82. Middle East and Africa Anti-intraocular Hypertension Drugs Revenue Market Share by Distribution Channel (2017-2028)
Figure 83. Middle East and Africa Anti-intraocular Hypertension Drugs Sales Share by Country (2017-2028)
Figure 84. Middle East and Africa Anti-intraocular Hypertension Drugs Revenue Share by Country (2017-2028)
Figure 85. Turkey Anti-intraocular Hypertension Drugs Revenue (2017-2028) & (US$ Million)
Figure 86. Saudi Arabia Anti-intraocular Hypertension Drugs Revenue (2017-2028) & (US$ Million)
Figure 87. UAE Anti-intraocular Hypertension Drugs Revenue (2017-2028) & (US$ Million)
Figure 88. Anti-intraocular Hypertension Drugs Value Chain
Figure 89. Anti-intraocular Hypertension Drugs Production Process
Figure 90. Channels of Distribution
Figure 91. Distributors Profiles
Figure 92. Bottom-up and Top-down Approaches for This Report
Figure 93. Data Triangulation
Figure 94. Key Executives Interviewed

---